Cargando…
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Studies of lactic acid bacteria (LAB) as delivery vehicles have focused mainly on the development of mucosal vaccines, with much effort being devoted to the generation of genetic tools for antigen expression in different bacterial locations. Subsequently, interleukins have been co-expressed with ant...
Autores principales: | Wells, Jerry M., Mercenier, Annick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096801/ https://www.ncbi.nlm.nih.gov/pubmed/18345021 http://dx.doi.org/10.1038/nrmicro1840 |
Ejemplares similares
-
Lactic Acid Bacteria for Delivery of Endogenous or Engineered Therapeutic Molecules
por: Bron, Peter A., et al.
Publicado: (2018) -
Development of Mucosal Vaccines Based on Lactic Acid Bacteria
por: Bermúdez-Humarán, Luis G., et al.
Publicado: (2009) -
Recombinant lactic acid bacteria as promising vectors for mucosal vaccination
por: Qiao, Nan, et al.
Publicado: (2021) -
Lactic Acid as a Prophylactic in Gout
Publicado: (1892) -
A Novel Lactic Acid Bacteria Mixture: Macrophage-Targeted Prophylactic Intervention in Colorectal Cancer Management
por: Hradicka, Petra, et al.
Publicado: (2020)